Srinivas G. Rao founded ATAI Life Sciences NV, Kyalin Biosciences, Inc., ATAI Life Sciences AG and IntroSpect Digital Therapeutics, Inc. Currently, Dr. Rao holds the position of Chief Executive Officer for EntheogeniX Biosciences, Inc., Chief Medical Officer of Gaba Therapeutics, Inc. and Chief Scientific Officer at ATAI Life Sciences NV, Chief Executive Officer & Director at Kures, Inc. and Chief Scientific Officer of ATAI Life Sciences AG (both are subsidiaries of ATAI Life Sciences NV). Srinivas G. Rao is also on the board of IntelGenx Technologies Corp. and Member of American Pain Society, Member of Society For Neuroscience and Member of American College of Neuropsychopharmacology.
In the past he occupied the position of Chief Scientific Officer of Sova Pharmaceuticals, Inc., Chief Medical Officer for Axial Therapeutics, Inc., Executive VP & Head-Neuroscience Division at Travere Therapeutics, Inc. and Chief Executive Officer of Kyalin Biosciences, Inc. (a subsidiary of Travere Therapeutics, Inc.), Chief Scientific Officer & Science Director at Cypress Bioscience, Inc., Chief Medical Officer & Senior Vice President of Assertio Therapeutics, Inc. and Member of International Association for the Study of Pain.
Srinivas G. Rao received a doctorate from Yale School of Medicine and a doctorate from Yale Graduate School of Arts & Sciences.